The cardiovascular drug developer, which had raised $94m from investors including Sanofi, priced its initial public offering considerably below the range set last week.

The France-based streaming platform, backed by Access Industries and Orange, has cancelled an IPO that was expected to generate more than $330m in proceeds.

The meal delivery service, in which Rocket Internet holds a majority stake, has filed to go public in Germany, a month after raising money at a $3bn valuation.

Backed by Novo, Johnson & Johnson, Novartis and Pfizer, the immuno-oncology drug developer was previously reported in April 2015 to be seeking a $105m offering.

Novo and Lundbeck-backed Acacia Pharma has postponed a $230m initial public offering in London as the healthcare IPO market continues to slow.

China-based immuno-oncology company BeiGene, which has raised more than $170m in the past year, will advance four of its drug candidates with the proceeds.

Vipshop will pay $34m for a stake in flash sales site Showroomprive, which is seeking $339m in a Paris IPO.

The Yuekeung Winery-backed alcohol e-commerce company, which has raised about $225m in funding, has had a Chinese IPO approved.

Citi, Starbucks and Visa are all investors but none are among the main shareholders of the payment processor, which last raised money at a $6bn valuation.

The Access and Orange-backed music streaming service expects to float at the end of this month, with ProSiebenSat1 and several record labels to secure shares.